US Patent 8652470 Monoclonal antibodies directed to CD52
Patent 8652470 was granted and assigned to VET THERAPEUTICS, INC. on February, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 1 Dec, 2023
Golden AI
Edits made to:
Article (+162 characters)
Article
Patent abstract
The invention provides antibody to canine or feline or equine antigens, e.g., canine CDS2, and methods of making and using antibodies as described.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08652470 Monoclonal antibodies directed to CD52 US Patent 8652470 Monoclonal antibodies directed to CD52
Infobox
Patent Number
0865247000
Patent Number
865247000
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
086524700
Date of Patent
February 18, 2014
0Patent Application Number
130401700
Date Filed
March 3, 2011
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
086524700
Date of Patent
February 18, 2014
0Patent Application Number
130401700
Date Filed
March 3, 2011
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08652470 Monoclonal antibodies directed to CD52
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08652470
Date of patent
February 18, 2014
Patent application number
13040170
Date Filed
March 3, 2011
Patent primary examiner
Find more entities like US Patent 8652470 Monoclonal antibodies directed to CD52
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
